Trial intelligence / Profile preview

Effects of midazolam induction on perioperative hemodynamics and postoperative recovery

ChiCTR2300073713Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of midazolam (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Blood pressure (systolic, diastolic, mean arterial pressure), Heart rate and 3 more. Planned start Oct 2023; status: not yet recruiting.

02

Drugs

midazolam

Beyond the preview

Go deeper on ChiCTR2300073713.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300073713.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call